BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30655850)

  • 1. Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF.
    Xie H; Lu Q; Wang H; Zhu X; Guan Z
    Oncol Lett; 2019 Jan; 17(1):933-936. PubMed ID: 30655850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical study of paclitaxel combined with FOLFOX4 regimen as neoadjuvant chemotherapy for advanced gastric cancer].
    Qu JJ; Shi YR; Liu FR; Ma SQ; Ma FY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep; 13(9):664-7. PubMed ID: 20878572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FOLFOX4 regimen versus DP(O)F regimen for advanced gastric cancer].
    Wu F; Zhang HG; Ran FW; Zhang XR; Shi YK
    Ai Zheng; 2008 Apr; 27(4):413-7. PubMed ID: 18423129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
    Tai Q; Shao H; Liu Y; Li E; Zhao R
    J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of FOLFOX4 combined with
    Chen Z; Zhou Z; Hu Z; Xu Q; Wang J
    Oncol Lett; 2018 Jan; 15(1):1079-1083. PubMed ID: 29399168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
    Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
    Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Controlled Study Comparing Efficacy and Toxicity of Weekly vs. 3-Weekly Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Tousif D; Sarathy V; Kumar R; Naik R
    Front Oncol; 2020; 10():1284. PubMed ID: 32850394
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma.
    Zhang XL; Shi HJ; Cui SZ; Tang YQ; Ba MC
    Eur J Surg Oncol; 2011 Jun; 37(6):466-72. PubMed ID: 21414740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study on treatment of advanced colorectal cancer by Aidi injection combined with FOLFOX4 regimen and by FOLFOX4 regimen alone].
    Li HJ; Dong L; Fu SY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1086-9. PubMed ID: 18198641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage III colorectal cancer].
    Lu GC; Fang F; Li DC
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):152-5. PubMed ID: 20403249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies.
    Ohtani H; Arimoto Y; Nishio K; Kanamiya Y; Oba H; Adachi K; Shintani M; Nakamura R; Yui S
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1769-74. PubMed ID: 18931586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost minimization analysis of capecitabine versus 5-fluorouracil-based treatment for gastric cancer patients in Hong Kong.
    Zhou KR; Cheng A; Ng WT; Kwok TY; Yip EY; Yao R; Leung PY; Lee VW
    J Med Econ; 2017 May; 20(5):541-548. PubMed ID: 28277030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-Trans-Retinoic Acid Plus Oxaliplatin/Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma with Pulmonary Metastasis: A Multicenter Retrospective Study.
    Sun J; Liu C; Wang N; Jiang D; Zhang F; Shi J; Cheng S
    Cancer Manag Res; 2022; 14():1663-1670. PubMed ID: 35547598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
    Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
    Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective analysis of FOLFOX4 neurotoxicity for recovery from advanced colorectal cancer].
    Matsuda M; Matsusaka S; Kuboki Y; Itimura T; Ogura M; Suenaga M; Syouji D; Watanabe C; Chin K; Mizunuma N; Hatake K
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):461-6. PubMed ID: 18347395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin, 5Fluorouracil and Leucovorin (FOLFOX4) as First Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer.
    Haghighi S; Kasbkar H; Esmaeilpour K; Yasaei M
    Asian Pac J Cancer Prev; 2016; 17(7):3277-80. PubMed ID: 27509963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Alternative and High Safety Profile of Acupuncture Plus Chemotherapy for Advanced Gastric Cancer.
    Miao X; Wu H; Liu Y; Zhang S; Li C; Hao J
    Evid Based Complement Alternat Med; 2022; 2022():8701779. PubMed ID: 35942375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
    Goldberg RM; Sargent DJ; Morton RF; Fuchs CS; Ramanathan RK; Williamson SK; Findlay BP; Pitot HC; Alberts S
    J Clin Oncol; 2006 Jul; 24(21):3347-53. PubMed ID: 16849748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Efficacy of Modified
    Wu H; Miao X; Liu Y; Zhang S; Li C; Hao J
    Evid Based Complement Alternat Med; 2022; 2022():6234032. PubMed ID: 35571732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.